News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
...
Agomab Therapeutics to Acquire Origo Biopharma
The acquisition strengthens Agomab as a leader in targeting growth factor pathways Origo Biopharma…
Partners - Asabys Partners
foo integra
Integra Therapeutics secures €4.5-million in funding from AdBio Partners, Invivo Capital and Takeda Ventures
Advanced therapies · Gene editing
Integra is a biotechnology company that is creating next-generation gene writing tools to boost the…
Partners - Integra Therapeutics S.L.
foto
New generation of digitised biosensors for cutting-edge food analytical monitoring
Food & feed
The food industry is no stranger to changes and adapts in order to maintain its competitiveness and…
Partners - Biolan
foto protqsar
A new in silico platform that facilitates the evaluation of mutagenicity with regulatory validity launched
Mutagenicity (capacity to alter cellular genetic material) is one of the most important parameters…
Partners - ProtoQSAR
auto test covid
Note from AseBio on recent regulation actions affecting the sale of diagnostics test kits available at pharmacies, during the current covid-19 situation
Coronavirus
AseBio regrets the fact that Spanish manufacturers of SARS-CoV-2 antigen detection tests have not…
bayer
Bayer and Mammoth Biosciences to collaborate on novel gene editing technology
Healthcare · Gene editing
Agreement strengthens Bayer’s new cell and gene therapy platform further / Supports Mammoth’s…
Partners - Bayer Hispania S.L
récord 284 socios
AseBio sees record number of members
The association has more than 284 members, 65.5% of which focus on biotechnology for healthcare,…
imagen AKRN
Amendment for the transition of in vitro diagnostic medical devices (IVDs) to the EU 2017/746 (IVDR)
This amendment aims to extend the scope and timelines for the transition to the new regulation and…
Partners - NAMSA
illumina
Multiomics is revolutionizing research, here’s why
Learn why research leaders decided to use Multiomics in their work.  
Partners - Illumina